Opexa Therapeutics Announces News Release Schedule For Third Quarter 2015 Financial Results

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and neuromyelitis optica (NMO), today announced that the Company will report financial results for the three months ended September 30, 2015 after the close of trading on Tuesday, November 10th.

Help employers find you! Check out all the jobs and post your resume.